Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000006710
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
NDF-RT |
N0000175521
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
NCI_THESAURUS |
C225
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
NDF-RT |
N0000006710
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
WHO-VATC |
QL03AB09
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
NDF-RT |
N0000006710
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
WHO-ATC |
L03AB09
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
INFERGEN (WITHDRAWN: HEPATITIS C, CHRONIC)
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C121542
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
ALTERNATIVE | |||
|
C050739
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
FF-78
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
56588OP40D
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
DB00069
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
7559
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
118390-30-0
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
2043378-94-3
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID4040507
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201557
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
INTERFERON ALFACON-1
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
Interferon Alfacon-1
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
m6304
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
C1766
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
409114-25-6
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
SUPERSEDED | |||
|
59744
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB08199MIG
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
C1766
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
100000085461
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY